share_log

HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29

HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29

HC Wainwright & Co.维持对Cullinan Oncology的买入,将目标股价下调至29美元
Moomoo 24/7 ·  04/17 05:36

HC Wainwright & Co. analyst Edward White maintains Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $34 to $29.

HC Wainwright & Co. 分析师爱德华·怀特维持库里南肿瘤学(纳斯达克股票代码:CGEM)的买入并将目标股价从34美元下调至29美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发